Your Guide to Submission

Thank you for your interest in submitting an abstract to DDW. Updated 2022 submission guidelines are available below.

The deadline to submit an abstract was Thursday, Dec. 2, 2021. Co-authors are reminded that disclosures are due Friday, Dec. 10, 2021, at 15:00 Eastern time (UTC -5).

Gloved hands typing on a laptop

Mark your calendar for these important dates related to DDW 2022 abstract submission:

  • Thursday, Oct. 21, 2021, at 09:00 Eastern time (UTC –4): Abstract submission site opened.
  • Thursday, Dec. 2, 2021, at 21:00 Eastern time (UTC –5): Abstract submission site closed. No abstract edits, author additions or changes to author information will be accepted after this deadline. Please note this deadline occurs on the Thursday after the U.S. Thanksgiving holiday.
  • Friday, Dec. 10, 2021, at 15:00 Eastern time (UTC –5): Co-author financial disclosures due.
  • Tuesday, Feb. 15, 2022: Acceptance notifications sent by email to presenting authors.

The following timeline applies to late-breaking abstract submissions:

  • Thursday, March 24, 2022, at 09:00 Eastern time (UTC –4): Late-breaking submission site opens.
  • Thursday, March 31, 2021, at 17:00 Eastern time (UTC –4): Late-breaking submission site closes.
  • Thursday, April 7, 2022, at 15:00 Eastern time (UTC –4): : Co-author financial disclosures due.
  • Tuesday, April 28, 2022: Acceptance notifications sent by email to presenting authors.

Submitting authors must create an account and submit abstracts online. No faxed or mailed abstracts will be accepted.

There is a $60 non-refundable processing charge per abstract. There is a $120 fee for late-breaking abstracts. Please note that this is a processing fee, not a publishing fee, and that abstracts not selected for presentation at DDW are also subject to the fee. Refunds will not be offered for any abstracts not selected for DDW 2022, to any presenting authors who are not able to attend DDW, or to authors who withdraw their abstracts.

Abstracts are not considered submitted until payment information has been received. Authors have the option of paying by Visa®, MasterCard® or American Express®. No invoices, purchase orders or checks will be accepted. Authors may edit submitted abstracts until the submission deadline on Dec. 2, 2021.

To speed the submission process, please ensure that your browser allows pop-ups and redirects for the abstract site before you submit. If pop-ups are blocked, the payment page may not display properly. Should you have any issues navigating the payment screen, use the tab key to advance fields.

For full instructions on submitting your abstract, view this brief tutorial.

For the 2022 meeting, DDW will offer in-person and virtual presentation options:

 

Oral and Poster Submissions
Abstracts submitted for oral or poster presentation will be considered for presentation on-site at DDW 2022 in San Diego, CA. If an abstract is selected for presentation, the presenting author is required to register for and attend DDW 2022 in person and present their abstract at the San Diego Convention Center at the date and time specified in their acceptance notification.

 

ASGE and SSAT Video Abstract Submissions
Video abstracts submitted to ASGE or SSAT by the Dec. 2 deadline will also be considered for presentation on-site at DDW 2022. If a video abstract is selected by ASGE or SSAT, the presenting author must attend DDW 2022 in person to provide live narration to the video at the date and time specified in the abstract acceptance notification.

 

ePoster Submissions
Authors unable to attend DDW in person in San Diego should select the “ePoster only” presentation option when submitting their abstract. ePoster-only abstract submissions will be considered for electronic presentation at the DDW ePosters site during DDW 2022. If selected for presentation, ePoster presenters are required to register for DDW and present their abstracts online at the date and time specified in their acceptance notification.

Society Membership
Authors do not have to be a member of one of the four sponsoring societies to submit an abstract. Submissions from international or trainee authors are welcome.

Abstract Eligibility

  • Abstracts containing basic, clinical or translational research findings in the fields of gastroenterology, hepatology, endoscopy or gastrointestinal surgery may be submitted.
  • Abstracts will not be considered for presentation if they have been published as an article or have been accepted for publication (including manuscripts) in printed or electronic formats upon the Dec. 2 submission deadline. (SSAT submitters: Please see further information in the SSAT Additional Rules section below.)
  • Abstracts that have been submitted to or presented at other national or international meetings, with the exception of the AASLD Liver Meeting, may be submitted provided that prior presentation and/or submission to other meetings is declared during the DDW submission process.
  • Abstracts presented at previous DDW meetings are not eligible for submission.
  • Abstracts that have been submitted to DDW in previous years, but not accepted for presentation, may be resubmitted.

Contact DDW Administration to verify that your abstract is eligible for submission to DDW 2022.

When submitting an abstract, authors must select the society to which they wish to submit as well as a submission category and subcategory. Abstracts may not be duplicated in any way or submitted to more than one society or submission category.

View the full list of abstract submission categories.

For questions about specific submission categories, contact the appropriate sponsoring society:

  • Abstract titles may not be longer than 255 characters, including spaces. Identifying information like author or institution names must not be included in the title. Abstract titles must be fully capitalized, but authors can format to add superscript or subscript during submission.
  • There is limit of 2,900 characters, including spaces, for the abstract text. Information included in tables or images does not count toward this limit.
  • Abstracts may include up to two images per abstract.
    • Images will only be accepted in gif, png, tiff, tif, jpg, or jpeg formats. PDFs will not be accepted.
    • Any author wishing to include a table with their abstract must submit the table as an image file type. For assistance with saving a Word, Excel or PowerPoint table as an image file, view these instructions on taking a screen shot using Windows or using a Mac.
    • Images will be published as submitted if accepted for presentation. Authors should remove large borders from images. Large images may be scaled for publication.
  • Abbreviations should conform to the recommendations made by the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology. Use the abbreviation in parentheses after the full word the first time it appears. Use no more than three nonstandard abbreviations.
  • Drug products mentioned in abstracts should be identified by their nonproprietary (i.e., generic) names only. Do not capitalize nonproprietary names.

Video abstracts may be submitted to either ASGE or SSAT for consideration for presentation during society forums. Video files must be in either MOV, MPG, MPG4, or MP4 formats and may not exceed 1 GB in size. All DDW rules and author requirements apply for video submissions.

 

If you have any technical difficulties during your file upload, please contact DDW Administration.

 

ASGE Video Submissions
ASGE video forums are designed to showcase interesting endoscopic cases or techniques in the field of gastrointestinal endoscopy. Video presentations can demonstrate accepted techniques, difficult or interesting cases, complications or innovations within the field of endoscopy.

 

Videos may be submitted for consideration for one of the following sessions:

 

Video Plenary: This session represents the most prestigious and highest ranking, cutting-edge, fully edited endoscopic videos presented at DDW. These submitted videos receive the top ratings during our peer review. The highest scoring video from the peer-reviewed process for each category will be presented an award by the moderators at the end of each section as “Best of the Best” in that category. However, there is no guarantee that each category will have an award given. In addition, one final overall winner (the ASGE-Video GIE Award) will be selected from those identified as “Best of the Best” videos. This award will be announced at the end of the Video Plenary session.

 

World Cup of Endoscopy: This session features a friendly international competition of selected videos from various countries. Selection for the World Cup will be based upon the entertaining content of the video, with the objective of selecting one video from several countries. On average every year, approximately eight to 10 countries compete in this session. All selected videos will be presented and scored live by an international panel of judges during the session. The top three winners will be declared at the end of the session and receive medals. This session is intended to foster a fun, relaxed and entertaining atmosphere!

 

Educational Endoscopy: What’s your favorite endoscopy technique? These cutting-edge, fully edited short topic specific educational endoscopic videos clips will be presented at DDW and must be eight minutes or less in duration. The highest scoring video for the best video in this category from the peer-reviewed process will be presented the Distinguished Educational Video (DEV) Award. This award will be announced at the end of the Video Plenary session.

 

For all ASGE video submissions:

 

  • All ASGE video submissions require an abstract and will follow the same rules and guidelines as abstracts submitted for oral and poster presentation.
  • All submissions are subjected to a peer-review process and evaluated according to content and audiovisual quality, determining which submission will be accepted and in which category.
  • Once submitted, you will NOT be able to make changes to the video or audio of the program.
  • Audio narration in English must be included in the production.
  • Convert your presentation into MP4 or MOV file.
  • Video size recommended for high definition:
    • 1920x1080 (square pixel ratio) or 1280x720 (square pixel ratio), both for 16:9 aspect ratio.
    • Bit Rate: 5Mbps (for 720) or 10Mbps (for 1080).
  • Video size recommended for standard definition:
    • 720x480 (0.9 pixel ratio) for a 4:3 aspect ratio or 720x480 (1.2 pixel ratio) for 16:9 aspect ratio.

For full rules and instructions on formatting your video, please review the following documents:

Email ASGE with questions about submitting a video abstract.

 

SSAT Video Submissions

  • A text abstract submission is required. Text should include the key ideas from the video. There is a limit of 255 characters for the title of your abstract submission. There is a limit of 700 characters, including spaces, for the text of your abstract submission (abstract body). Do not include institution or author names in the title, abstract body or file name.
  • Attribution for commercial support must be in the form of a video credit in the beginning of the program. No endorsement or promotion of a specific device or product is allowed. Non-FDA approved use of devices should also be indicated in the opening credits of the video.
  • Duration of the video should be seven to 10 minutes. Videos longer than 10 minutes will not be considered. Although sound is encouraged with video submission so that its content may be properly evaluated, if selected for presentation, no audio playback capabilities will be provided. The presenting author will need to supply all narration to the video itself.
  • Permission for all copyrighted material (drawings, illustrations, video footage) must be obtained with attribution of permissions included in the closing credits.
  • Surgical videos submitted online should not include author and institution information. Any patient identifying information must be excluded or obscured from video films and narration.
  • If accepted, changes cannot be made to the submitted video file as videos will be uploaded on your behalf prior to the start of the meeting for conversion/playback purposes. If a PowerPoint presentation is required for introduction, you must indicate this in the submission.

By submitting an abstract, the contact author certifies that they and all co-authors listed on the abstract have read and agree to the following DDW 2022 Rules for Submission. Violations of any DDW policies may result in a five-year sanction from submitting abstracts to DDW for the submitting author.

Commitment to Present

  • Submission of an abstract constitutes a commitment by the author(s) to present if the abstract (if selected for presentation) at the date, time and location specified in the acceptance notification. is accepted.
    • Presenting authors of abstracts selected for oral, poster or ASGE or SSAT video presentation must attend DDW 2022 in person to present their abstract on-site at the San Diego Convention Center.
    • Presenting authors of abstracts selected for ePoster presentation are required to present their abstract virtually during DDW 2022 at the date and time specified in their invitation.
  • Failure to present may jeopardize acceptance of future abstracts.
  • Abstracts may be presented only by authors listed in the author string at the time of submission.
  • All presentations at DDW 2022 will be in English. Oral abstract presentations must be made by an author who speaks and understands English.
  • Presenters are required to register for the meeting. Registration opens on Wednesday, Jan. 19, 2022, for society members and Wednesday, Jan. 26, 2022, for nonmembers.
  • Expenses associated with the submission and presentation of an abstract are the sole responsibility of the presenting author.
  • All data presented at DDW is embargoed for the beginning of its presentation time or an official DDW press conference, whichever occurs first. View DDW media and embargo policies.

Previous Presentation, Publication and Duplication

  • As the world’s largest gathering of physicians and researchers in the GI field, DDW encourages the submission of abstracts that have not yet been presented at other large medical meetings. Abstracts that have been submitted to or presented at other national or international meetings, with the exception of the AASLD Liver Meeting, may be submitted provided that prior presentation and/or submission to other meetings is declared during the DDW submission process.
  • Abstracts presented at previous DDW meetings are not eligible for submission.
  • Abstracts will not be considered for presentation if they have been published as an article or have been accepted for publication (including manuscripts) in printed or electronic formats upon the Dec. 2 submission deadline.
  • Abstracts will not be considered for presentation if they have been duplicated in any way. Abstracts may not be submitted to more than one category, subcategory or society for DDW.
  • Abstracts that have been submitted to DDW in previous years but not accepted for presentation are eligible for submission.
  • DDW reserves the right to impose a five-year sanction on any author who submits an abstract that has been duplicated in any way or submits an abstract to more than one category, subcategory or society.

Corresponding Authors
The corresponding author certifies that all authors named in his abstract have agreed to its submission for presentation at DDW 2022; that any animal studies conform with the October 2014 revision of The Guiding Principles in the Care and Use of Vertebrate Animals in Research and Training by the American Physiological Society; and that any human experimentation conducted conforms with the principals of the Declaration of Helsinki of the World Medical Association and meets all the requirements governing informed consent of the country in which the research was performed.

Co-Author Participation
By submitting an abstract, the corresponding author affirms that his co-authors have participated sufficiently in the intellectual content, the analysis of data and the writing of the abstract to take public responsibility for it.

Ethical Statement
Corresponding authors affirm that they and the other authors submitting an abstract to DDW certify that the data included in their abstract submission and/or presented at DDW is truthful, original, unduplicated and without fraud or fabrication.

Abstract Copyright Transfer Agreement and Release for Recording
By submitting an abstract, the corresponding author hereby assigns, conveys, and otherwise transfers all rights, title, interest, and copyright ownership in said work to the four sponsoring societies of DDW effective upon acceptance of said work for publication. “Work” includes the material submitted for publication and any other related material submitted to DDW. The assignment of rights to the four sponsoring societies of DDW includes but is not expressly limited to rights to edit, publish, reproduce, distribute copies, prepare derivative works, include in indices or search databases in print, electronic, or other media, whether or not in use at the time of execution of this agreement, and claim copyright in said work throughout the world for the full duration of the copyright and any renewals or extensions thereof.

The corresponding author also certifies upon abstract submission that all authors named in the abstract have read and agree to the terms of the above DDW Abstracts Copyright Transfer Agreement and Release for Recording.

U.S. Government Employee Authors
The corresponding author warrants that the work was authored by employees of the U.S. government as part of their official duties and therefore may be published and reproduced without restriction.

Disclosure Compliance

  • All authors are required to complete the disclosure process at the abstract submission site either disclosing all financial relationships with commercial interests or indicating that none exist. The deadline for completing disclosure is Friday, Dec. 10, 2021, at 3 p.m. EST.
  • Abstracts missing co-author financial disclosures will be in jeopardy of not being reviewed and involuntarily withdrawn from DDW 2022.
  • It is the submitting author’s responsibility to ensure that all co-authors submit their financial disclosure for DDW 2022.
  • Submitting authors are not permitted to submit a disclosure on a co-author’s behalf.

AGA Institute Oral and Poster Abstract Submission

  • AGA welcomes abstract submissions from all career levels for consideration of oral or poster presentation.
  • Please carefully and thoroughly review the AGA Institute Council’s list of expanded abstract descriptors to find the best category and subcategory for your abstract submission.
  • Abstracts submitted to the incorrect category or subcategory may be reassigned.

AGA GI Fellow-Directed QI Session Abstract Submission

  • AGA will accept submissions for oral, poster or eposter presentation at a special fellow-directed session focusing on quality improvement.
  • Only those currently enrolled in a GI fellowship program may submit abstracts to this descriptor category.
  • The GI fellow MUST be the primary author on the abstract submission.
  • Medical residents are not eligible to submit abstracts to this category.
  • Abstracts submitted and accepted under this category are only eligible for presentation at the special quality improvement session.
  • Please select “GI Fellow-Directed QI Session” for your category and subcategory only if you are submitting for this session.

ASGE Case Report Submissions
New for 2022, this category permits fellows and trainees to submit cases involving five or fewer patients that have pertinent training points or that amplify clinical experiences. Examples could include a series of interesting or challenging cases or a report illustrating an unusual case or variation on a disease that may differ from the traditional textbook information.

Authors are encouraged to submit a video along with written abstract. Videos submitted in this category will only be presented if accepted to an oral session.

  • Abstracts submitted to this category are eligible for oral, poster, or eposter presentation.
  • Only those currently enrolled in a medical school, residency, or fellowship training program may submit abstracts to this category. Co-authors do not need to be students, residents, fellows, or trainees.
  • The student, resident, fellow, or trainee MUST be listed as the primary AND presenting author on the abstract submission.
  • Entries must be oriented towards GI Training.
  • Case Reports will not be considered for presentation if they have been accepted for publication or will be published as an article (includes manuscripts accepted for publication) in either printed or electronic format upon the Dec. 2 abstract submission deadline.
  • Case Reports may not be submitted to more than one category, subcategory, or society for DDW.
  • Violations of these policies could result in a 5-year sanction for submitting abstracts to DDW for the submitting author.
  • Case report submitters are encouraged (but not required) to submit a video along with written abstract.
  • Videos should illustrate endoscopic findings or techniques that enhance the case report.
  • Videos must be one minute or less in length. Case report submissions containing videos longer than one minute will be automatically rejected.
  • Videos will only be presented if accepted to an oral session.
  • Narration is not necessary but if included, must be in English.
  • Any potential conflict of interest must be disclosed by ALL authors. A potential conflict of interest exists when an author or the author's institution has financial or personal relationships that could influence or could be perceived to influence the case presentation. If there are no conflicts of interest, authors must state that there are none. Authors must use the DDW abstract submission disclosure form, which is completed through the submission process.
  • Commercial support for the video production may be acknowledged with a single credit line acknowledging the company/organization providing the support.
  • Case Reports CANNOT contain product specific endorsements/group messages or advertising. Do not put product brand names or drug brand names in the video. Generic product and drug names should be used. Efforts must be taken to “black out” any product names that appear within the video. For all narration, when referring to a specific product, you must use the generic term; not doing so could result in an AUTOMATIC REJECTION.
  • Case Report images or videos CANNOT contain institutional names or logos. Case Reports that contain institutional names and logos will be AUTOMATICALLY REJECTED
  • Case Report videos CANNOT contain any copyrighted images, videos, photos, etc. (including those obtained from the internet such as a manufacturer’s website) without supporting documentation from the originating source of the copyrighted work. Videos that contain copyrighted images without this documentation will be AUTOMATICALLY REJECTED.
  • Case Reports submissions and videos CANNOT contain any patient information, physician names, medical record numbers, etc. Videos must be HIPAA (Health Insurance Portability and Accountability Act of 1996) compliant. If there are any perceived HIPAA violations, the submission will be AUTOMATICALLY REJECTED. Please check the endoscopy video and fluoroscopy video portions as well as these have been commonly missed in the past.
  • Copyright must be assigned to the ASGE by ALL authors.
  • Video must be formatted in one of the following types: MP4 (.mpg) or QuickTime (.mov). Other video file formats will not be accepted. Do NOT submit .wmv files.
  • It is recommended that all submissions be submitted in high definition with a recommended video size of  1920x1080 (square pixel ratio) or 1280x720 (square pixel ratio), both for 16:9 aspect ratio. Bit Rate: 5Mbps (for 720) or 10 Mbps (for 1080).
  • Video size recommended for standard definition: 720x480 (0.9 pixel ratio) for a 4:3 aspect ratio or 720x480 (1.2 pixel ratio) for 16:9 aspect ratio.
  • Please be sure to use a video frame rate of 30 frames per second.
  • To ensure good image quality, a video data rate between 3-10 Mbit/second is recommended.

  • The SSAT will consider abstract submissions for presentation if they have been previously published, or have been accepted for publication at the time of submission, provided that the previous publication is disclosed and that substantive updates from the previous work are demonstrated during the DDW submission process.
  • If an abstract selected for an SSAT Plenary or Quick Shot presentation describes the use of a device, product or drug that is not FDA approved; off-label use of an approved device, product or drug; or unapproved usage of a device, product or drug, the presenting author is required to disclose this information verbally to the learner during his or her presentation.
  • Authors of abstracts selected for SSAT presentations are encouraged to submit a manuscript for potential publication in the Journal of Gastrointestinal Surgery.

All authors are required to complete the disclosure process by either disclosing all financial relationships with commercial interests or indicating that none exist. The deadline for completing all disclosures is 3 p.m. EST on Friday, Dec. 10, 2021, for general submissions and 3 p.m. EDT on Thursday, April 7, 2022, for late-breaking submissions.

 

It is the submitting author’s responsibility to ensure that all co-authors submit their financial disclosure for DDW 2022. Submitting authors are not permitted to submit a disclosure on a co-author’s behalf.

 

Upon submission of an abstract, all co-authors will receive an email message informing them that they have been listed as a co-author of an abstract and that they are required to complete financial disclosure. The message will contain a link co-authors may use to log into the abstract submission site to complete the disclosure form.

 

As part of the disclosure process, authors will be asked if they have any relationships with commercial interests. Authors with such relationships will be asked to list the name(s) of the companies with which they are involved, the benefits received (e.g., salary, consulting fee, ownership interest, etc.) and any roles they play within the named commercial entities (e.g., advisory committee member, board member, employee, shareholder, etc.). Authors without relationships may state that they have no information to disclose.

 

For more information on submitting disclosure, view this brief tutorial.

Authors may make edits to submitted abstracts any time prior to the Dec. 2 submission deadline. To make edits, submitting authors should log in at the submission site, click the “submission” tab and use the dropdown menu next to the abstract title to select “return to draft.” The abstract will then be available for editing. Once all changes have been made, authors must save and resubmit the abstract. Please note that authors must resubmit an abstract that has been edited after the initial submission. Any abstracts in draft status at the submission deadline will not be reviewed or considered for presentation at DDW. There is no fee to resubmit an abstract.

  • Presenting authors will be notified of the status of their abstracts by email on Tuesday, Feb. 15, 2022. It is the responsibility of the presenting author to notify any co-authors of the decision.
  • Presenting authors must formally accept their invitations to present at the submission site by 5 p.m. EST on Wednesday, Feb. 23, 2022. If an invitation remains unanswered after this date, the abstract may be withdrawn.
  • Declined invitations will result in automatic withdrawal.
  • No refunds will be provided for declined or withdrawn abstracts.

DDW will withdraw an abstract upon written request from the submitting author. Requests for withdrawal must be made by Feb. 25, 2022. After this date, DDW cannot guarantee that a withdrawn abstract will be excluded from publication.

 

Requests to withdraw an abstract must be made by the submitting or presenting author and must contain the submitting author’s name, abstract title and control ID number. To withdraw an abstract, complete this form.

To give authors the opportunity to submit novel research that was not complete at the general submission deadline, DDW will accept clinical and basic science late-breaking abstract submissions from 09:00 Eastern time (UTC -4) on March 24, 2022, through 17:00 Eastern time (UTC –4) on Thursday, March 31, 2022.

 

Late-Breaking Abstract (LBA) submissions may be selected for oral presentation and should feature newsworthy, high-impact data that was not available at the Dec. 2 general submission deadline. Abstracts will be scored on the quality and significance of the submitted evidence. DDW welcomes submissions describing new therapies and unapproved medications, large phase II or III clinical trial results, and novel basic science discoveries that have not been published or presented at other meetings.

 

The LBA submission period is not an extension to the general submission period. Case reports, literature reviews, retrospective studies, and abstracts featuring results or data available on the Dec. 2 general submission deadline are ineligible as late-breaking abstracts and will not be considered. Revisions to previously submitted abstracts and abstracts that have been published or presented in any other scientific venue or journal prior to DDW 2022 are also ineligible and will not be reviewed. All formatting and submission rules apply to late-breaking submissions.

 

By submitting a late-breaking abstract, all authors acknowledge and agree to the following policies:

  • Submission of a late-breaking abstract constitutes an obligation to attend the late-breaking plenary session in person at DDW 2022 in San Diego if the abstract is accepted.
  • There is a $120 fee to submit a late-breaking abstract.
  • All formatting and submission rules listed in the DDW 2022 Abstract Submission Guidelines apply to late-breaking submissions, with the following exception: Any abstract that has been published or has been or will be presented at a meeting taking place prior to DDW 2022 is ineligible for submission as a late-breaking abstract.
  • After March 31, late-breaking submissions cannot be withdrawn. Abstracts accepted for presentation will not be able to be excluded from the DDW publications.

Abstracts selected for presentation at DDW 2022 by AASLD, AGA and SSAT will be published online in the May 2022 Gastroenterology supplement. Abstracts selected for presentation at DDW 2022 by ASGE will be published online in the  GIE: Gastrointestinal Endoscopy supplement.

DDW will award up to 20 Basic Science Travel Awards to early-career researchers for the 2022 meeting. Selected authors of basic science abstracts will receive a $1,000 grant and recognition at DDW 2022.

 

DDW's sponsoring societies also offer several grants for abstract authors. Learn more.

Contact DDW Administration to verify that your abstract is eligible for submission to DDW 2022.

Video Tutorials

This video playlist provides a step-by-step guide on how to submit an abstract, complete disclosures, convert tables to images and print a receipt. 

The deadline for all submissions is Thursday, Dec. 3 at 9 p.m. EST

Advice for Abstract Submission

Mindy Engevik, PhD

10 Ways to Make Your Abstract Stand Out

Ensure that your abstract stands out for acceptance to DDW by following these 10 recommendations from Mindy Engevik, PhD.

Dhruvil Radadiya, MD

What I Wish I Knew: 5 Lessons I Learned as an Abstract Submitter

Dhruvil Radadiya, MD, shares the five things that he wishes he knew before submitting his first abstract to DDW.

The Do’s and Don’ts of Abstract Submission

To help you craft the perfect abstract, Alana Persaud, MD, shares some do’s and don’ts.